Abstract

BackgroundThe Latrophilin 3 (LPHN3) gene (recently renamed Adhesion G protein‐coupled receptor L3 (ADGRL3)) has been linked to susceptibility to attention deficit/hyperactivity disorder (ADHD) and vulnerability to addiction. However, its role and function are not well understood as there are no known functional variants.MethodsTo characterize the function of this little known gene, we phenotyped Lphn3 null mice. We assessed motivation for food reward and working memory via instrumental responding tasks, motor coordination via rotarod, and depressive‐like behavior via forced swim. We also measured neurite outgrowth of primary hippocampal and cortical neuron cultures. Standard blood chemistries and blood counts were performed. Finally, we also evaluated the transcriptome in several brain regions.ResultsBehaviorally, loss of Lphn3 increases both reward motivation and activity levels. Lphn3 null mice display significantly greater instrumental responding for food than wild‐type mice, particularly under high response ratios, and swim incessantly during a forced swim assay. However, loss of Lphn3 does not interfere with working memory or motor coordination. Primary hippocampal and cortical neuron cultures demonstrate that null neurons display comparatively enhanced neurite outgrowth after 2 and 3 days in vitro. Standard blood chemistry panels reveal that nulls have low serum calcium levels. Finally, analysis of the transcriptome from prefrontal cortical, striatal, and hippocampal tissue at different developmental time points shows that loss of Lphn3 results in genotype‐dependent differential gene expression (DGE), particularly for cell adhesion molecules and calcium signaling proteins. Much of the DGE is attenuated with age, and is consistent with the idea that ADHD is associated with delayed cortical maturation.ConclusionsTranscriptome changes likely affect neuron structure and function, leading to behavioral anomalies consistent with both ADHD and addiction phenotypes. The data should further motivate analyses of Lphn3 function in the developmental timing of altered gene expression and calcium signaling, and their effects on neuronal structure/function during development.

Highlights

  • It is well established that attention deficit/hyperactivity disorder (ADHD) and substance use disorders (SUDs) have strong genetic components (Li and Burmeister 2009; Treutlein and Rietschel 2011; Arcos-Burgos et al 2012a; Gorwood et al 2012; Hart et al 2012), but there is still a paucity of information regarding reliable biomarkers for these diseases, which limits the ability to develop targeted therapies for their treatment

  • Standard blood chemistry panels reveal that nulls have low serum calcium levels

  • Analysis of the transcriptome from prefrontal cortical, striatal, and hippocampal tissue at different developmental time points shows that loss of Lphn3 results in genotype-dependent differential gene expression (DGE), for cell adhesion molecules and calcium signaling proteins

Read more

Summary

Introduction

It is well established that attention deficit/hyperactivity disorder (ADHD) and substance use disorders (SUDs) have strong genetic components (Li and Burmeister 2009; Treutlein and Rietschel 2011; Arcos-Burgos et al 2012a; Gorwood et al 2012; Hart et al 2012), but there is still a paucity of information regarding reliable biomarkers for these diseases, which limits the ability to develop targeted therapies for their treatment. Several genetic linkage and candidate gene association studies have identified the LPHN3 gene (OMIM 616417) as a candidate marker for ADHD and SUDs. Genome-wide linkage analyses in large multigenerational families have repeatedly shown that variants within the LPHN3 gene on Chromosome 4q confer risk of susceptibility to the development of ADHD and disruptive behaviors, such as SUDs (Arcos-Burgos and Muenke 2010; Arcos-Burgos et al 2010; Martinez et al 2011; Ribases et al 2011). Vulnerability to addiction is a complex trait with strong genetic influences that are largely shared by abusers of multiple legal and illegal addictive substances (Arcos-Burgos et al 2012a). Both linkage and association-based genome scans have been conducted for specific drug dependencies as well as for vulnerability to addiction. Its role and function are not well understood as there are no known functional variants

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call